These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4630485)

  • 1. The effect of nifurtimox in acute Chagas' infection.
    Wegner DH; Rohwedder RW
    Arzneimittelforschung; 1972 Sep; 22(9):1624-35. PubMed ID: 4630485
    [No Abstract]   [Full Text] [Related]  

  • 2. Experience with nifurtimox in chronic Chagas' infection. Preliminary report.
    Wegner DH; Rohwedder RW
    Arzneimittelforschung; 1972 Sep; 22(9):1635-41. PubMed ID: 4630486
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined treatment of Chagas' disease with Bayer 2502 and corticoid (experimental and clinical study)].
    Andrade SG; Macêdo V
    Rev Inst Med Trop Sao Paulo; 1973; 15(6):421-30. PubMed ID: 4209018
    [No Abstract]   [Full Text] [Related]  

  • 4. Animal experimental investigation into the activity of nifurtimox against Trypanosoma cruzi.
    Haberkorn A; Gönnert R
    Arzneimittelforschung; 1972 Sep; 22(9):1570-82. PubMed ID: 4630483
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical therapeutic trial in chronic Chagas' disease using nifurtimox in 3 schedules of long duration].
    Cancado JA; Salgado AA; Marra UD; Alvares JM; Machado JR
    Rev Inst Med Trop Sao Paulo; 1975; 17(2):111-27. PubMed ID: 807963
    [No Abstract]   [Full Text] [Related]  

  • 6. Nifurtimox: causal treatment of Chagas' disease.
    Gönnert R
    Arzneimittelforschung; 1972 Sep; 22(9):1563. PubMed ID: 4630481
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of patients with chronic Chagas' disease by means of the nitrofuran compound Bayer 2502 or Lampit].
    Levi GC; Amato Neto V
    Rev Inst Med Trop Sao Paulo; 1971; 13(5):369-72. PubMed ID: 5005700
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of chronic Chagas' infection with Lampit].
    Schenone H; Concha L; Aranda R; Rojas A; Knierim F; Rojo M
    Bol Chil Parasitol; 1972; 27(1):11-4. PubMed ID: 4628949
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of Chagas' disease with nifurtimox during the first months of life].
    Moya PR; Paolasso RD; Blanco S; Lapasset M; Sanmartino C; Basso B; Moretti E; Cura D
    Medicina (B Aires); 1985; 45(5):553-8. PubMed ID: 3939553
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chagas' disease: clastogenic effect of nifurtimox and benznidazole in children].
    Moya PR; Trombotto GT
    Medicina (B Aires); 1988; 48(5):487-91. PubMed ID: 3151216
    [No Abstract]   [Full Text] [Related]  

  • 11. [(Effect of Lampit on experimental Trypanosoma cruzi infection in mice)].
    Apt W; Mancilla R; Díaz M; Díaz S
    Bol Chil Parasitol; 1972; 27(3):80-6. PubMed ID: 4196829
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibility of treatment in Chagas' disease].
    Prata A
    AMB Rev Assoc Med Bras; 1978 Apr; 24(4):140-2. PubMed ID: 98813
    [No Abstract]   [Full Text] [Related]  

  • 13. [Electroencephalography findings in chronic Chagas' infection in children and young adults treated with Bay 2502].
    Girardelli MA
    Bol Chil Parasitol; 1969; 24(1):35-8. PubMed ID: 4983549
    [No Abstract]   [Full Text] [Related]  

  • 14. [Longitudinal study of the persistence of the therapeutic action of nifurtimox and benznidazole in patients with chronic chagas infection].
    Schenone H; Rojas A; Alfaro E; Concha L; Aranda R
    Bol Chil Parasitol; 1981; 36(3-4):59-62. PubMed ID: 6812600
    [No Abstract]   [Full Text] [Related]  

  • 15. The structure-activity relationship of 4-(5'-nitrofurfurylidene-amino)-tetrahydro-4H-1,4-thiazine-1,1-dioxides active against Trypanosoma cruzi.
    Bock M; Haberkorn A; Herlinger H; Mayer KH; Petersen S
    Arzneimittelforschung; 1972 Sep; 22(9):1564-9. PubMed ID: 4630482
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of nifurtimox on intra- and extracellular development stages of Toxoplasma gonii].
    Werner H; Gönnert R
    Arzneimittelforschung; 1974 May; 24(5):790-3. PubMed ID: 4408129
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxicological investigations on the tolerability of nifurtimox.
    Hoffmann K
    Arzneimittelforschung; 1972 Sep; 22(9):1590-603. PubMed ID: 4678717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Etiologic therapy of Chagas' disease].
    Boainain E; Rassi A
    Arq Bras Cardiol; 1979 Jun; 32(6):395-9. PubMed ID: 116629
    [No Abstract]   [Full Text] [Related]  

  • 19. [A study of 39 cases of acute Chagas' disease in Santa Cruz, Bolivia (author's transl)].
    Recacoechea M; De Muynck A; Zuna H; Bermudez H; Melgar B; Rivero A; Romero A; Ribera B
    Bol Chil Parasitol; 1979; 34(3-4):53-8. PubMed ID: 121538
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of complement mediated lysis technic in patients with chronic Chagas' disease treated with trypanocidal drugs].
    Levy AM; Pereira VL; Boainain E
    Rev Inst Med Trop Sao Paulo; 1988; 30(1):32-9. PubMed ID: 3146793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.